Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 445 of 6351
-
New surgery could give spinal cord injury patients a better chance at recovery
Disease control By invitation onlyThe goal of this clinical trial is to learn if a procedure called "expansile duraplasty" can improve recovery in adults who have experienced an acute traumatic spinal cord injury (SCI). The main questions it aims to answer are: * Does expansile duraplasty work to improve recover…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Healing from home: could Tele-Rehab soothe Post-C-Section back pain?
Symptom relief OngoingThe goal of this study is to learn whether tele-rehabilitation helps postpartum women recover from low back pain after a cesarean section (C-section). The study will also look at whether tele-rehabilitation helps reduce fatigue, improve psychological well-being, and make daily ac…
Sponsor: Shifa Tameer-e-Millat University • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
New infant vaccine trial aims to shield against pneumonia and meningitis
Vaccine Recruiting nowThe purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccine helps to fight against germs that can cause pneumonia (lung infections), meningitis (brain infections), and otitis media (ear infections) in infants when comp…
Phase 3 • Sponsor: Pfizer • Aim: Vaccine
Last updated Aug 12, 2026 00:00 UTC
-
New online therapy aims to ease PTSD after sexual abuse
Symptom relief Recruiting nowThis project aims to evaluate Restory - a newly developed anonymous, iCBT prolonged exposure therapy program specifically tailored for victims of sexual abuse - using a pre-registered randomized controlled trial with waitlist control. The primary research question is whether Rest…
Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
New drug infusion targets tough cancers in early trial
Disease control Recruiting nowThis study will help find the most suitable dose of ASP546C in people with gastric cancer, gastroesophageal junction (GEJ) cancer, pancreatic cancer, and other specific solid tumors. GEJ is where the food pipe (esophagus) joins the stomach. This study is in 2 parts. In both part…
Phase 1/2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can skipping opioids during mastectomy protect the immune system?
Symptom relief CompletedThis randomized controlled trial compares opioid-free anesthesia combined with pectoral nerve block (PECS I and II) with opioid-based anesthesia in patients undergoing modified radical mastectomy. The study evaluates postoperative CD4+ T-cell counts as a marker of cellular immune…
Sponsor: Muhammad Fiqhi Amiruddin • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
New immunotherapy MK-1045 takes on tough lymphomas
Disease control Recruiting nowResearchers are looking for new ways to treat 2 types of non-Hodgkin lymphoma (NHL) called follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL). FL is a slow-growing type of NHL. DLBCL is a fast-growing type of NHL. NHL is a cancer in the lymphatic system that cause…
Phase 1/2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a Skin-Derived graft match the gold standard for saving molars?
Disease control Recruiting nowThis study consists of two components evaluating furcation involvement in mandibular molars among Stage III or Stage IV periodontitis patients. Component 1 is a cross-sectional study evaluating the prevalence and morphological characteristics of Hamp Class II furcation defects du…
Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New program aims to break cycle of violence and malnutrition in tanzania
Prevention Recruiting nowThis cluster-randomized controlled trial will evaluate the effectiveness, implementation, and scalability of Familia Imara, a group-based, couples-focused, community health worker (CHW)-delivered parenting program, on reducing intimate partner violence (IPV), harsh discipline, an…
Sponsor: Saini Das • Aim: Prevention
Last updated Jun 27, 2026 13:02 UTC
-
Electric needles vs. stiff necks: a High-Tech test
Symptom relief Recruiting nowThis randomized, single-blind, placebo-controlled clinical trial aims to investigate the immediate physiological effects of a single session of electroacupuncture (EA) on neck muscle stiffness in individuals with chronic neck pain. While acupuncture is a widely used complementary…
Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
Can a new schizophrenia drug stay safe over the long haul?
Disease control OngoingThis study will evaluate the long-term real-world safety of xanomeline-trospium chloride in adults with schizophrenia receiving routine clinical care in the United States.
Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New combo therapy aims to improve leukemia remission
Disease control Recruiting nowThis is a phase II, open-label, multi-center study evaluating the efficacy and safety of sonrotoclax (SA) in combination with azacitidine (AZA) plus individualized targeted or chemotherapeutic agents in adult participants with newly diagnosed acute myeloid leukemia (AML). Eligibl…
Phase 2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New Imaging-Guided radiation aims to better control High-Risk prostate cancer
Disease control Not yet recruitingIn this study, prostate cancer patients whose cancer has not spread to the lymph nodes will receive radiation therapy targeted to the prostate and nearby tissues with or without whole pelvis radiation therapy. PSMA imaging will be used to visualize prostate cancer prior to starti…
Phase 2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New combo therapy aims to personalize throat cancer treatment
Disease control Not yet recruitingThis single-arm Phase I/II trial evaluates induction chemoimmunotherapy combined with lattice radiotherapy (LRT) in patients with non-low risk oropharyngeal squamous cell carcinoma and primary tumor ≥3 cm or primary tumor and pathologic lymph node ≥3 cm in longest dimension. BOIN…
Phase 1/2 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a blood spin help women with failed IVF get pregnant?
Disease control Not yet recruitingEndometrial receptivity is a key determinant of success in assisted reproductive technology (ART). A significant proportion of patients experience repeated implantation failure despite euploid embryos and adequate laboratory conditions. Thin endometrium, often defined as ultrasou…
Sponsor: Azienda Sanitaria Locale di Asti • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Pocket-Sized defibrillators for volunteers could revolutionize cardiac arrest response
Disease control Not yet recruitingThe goal of this clinical trial is to learn the feasibility of equipping the volunteer community responders (VCR) with the mobile external automated defibrillators (mAEDs) for the management of adults experiencing out-of-hospital cardiac arrest (OHCA) patients. It will also provi…
Sponsor: Singapore General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New drug cocktail shows promise against tough esophageal cancer
Disease control Not yet recruitingThe purpose of this study is to assess the efficacy and safety of QL1706 combined with nab-paclitaxel and cisplatin in first-line therapy for patients with advanced or metastatic esophageal squamous cell carcinoma. QL1706 is a anti-PD-1 and anti-CTLA4 antibody.
Phase 2 • Sponsor: The First Affiliated Hospital of Henan University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could a common steroid prevent a deadly complication in AIDS patients?
Prevention Not yet recruitingThis study was a multicenter, open-label, randomized controlled clinical trial designed to evaluate the efficacy and safety of glucocorticoids in preventing paradoxical immune reconstitution inflammatory syndrome (IRIS) in patients with AIDS complicated by opportunistic infection…
Sponsor: Shanghai Public Health Clinical Center • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Could a shock drug help ARDS patients breathe easier?
Disease control Not yet recruitingAcute respiratory distress syndrome (ARDS) is a life-threatening condition with a diffuse, inflammatory form of lung injury, causing pulmonary infiltration and respiratory failure leading to poor oxygenation. It is a rapidly progressive form of respiratory failure and accounts fo…
Phase 2 • Sponsor: Pharmazz, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New hope for rare leukemia: drug cocktail aims for remission
Disease control Not yet recruitingThis is a prospective, open-label, single-arm, two-cohort Phase 2 clinical study designed to evaluate the efficacy and safety of Bcl-2 Inhibitor combined with azacitidine (with blinatumomab added in B/myeloid subtype) in patients with newly diagnosed mixed phenotype acute leukemi…
Phase 2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC